Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Ontario-wide Cancer TArgeted Nucleic Acid Evaluation

NCT02906943 is registered in ClinicalTrials.gov with University Health Network, Toronto as lead sponsor.

NCT NCT02906943
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02906943 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Ontario-wide Cancer TArgeted Nucleic Acid Evaluation
Lead sponsor
University Health Network, Toronto
Phase
Observational
Overall status
Recruiting
Start date
August 31, 2016
Completion date
August 31, 2027
Enrollment
10,000 (estimated)
Sites
7

Conditions

As the registry lists them; a condition with its own page is linked.

breast cancer, colorectal cancer, gastrointestinal cancer, genitourinary cancer, gynecological cancer, head and neck cancer, lung cancer, melanoma, pancreatobiliary cancer, rare cancer, unknown primary cancer